Skip to content

LegitScript compliance blog

What changed, what it means, and what to do about it.

Expedited filing versus self-filing

What a complete application file actually looks like

A complete LegitScript application file is one where every question a reviewer could reasonably ask has already been answered in the submission, which in practice means five bodies of evidence assembled before filing rather than four assembled during the review.

· 6 min read

Direct-to-consumer telehealth brands

What a certification review looks for in an ED and men's health brand

Men's health brands are certified routinely, but ED and hair-loss categories draw a closer review of three things in particular: whether a genuine prescribing decision happens, whether the product is described accurately, and whether a subscription can actually be cancelled.

· 5 min read

Telehealth clinic compliance

Your pharmacy partner is part of your application

A certification reviewer assesses the pharmacy that dispenses for your clinic as closely as it assesses the clinic itself, and a partner whose NABP accreditation, permitted activities or interstate licensing cannot be verified becomes your problem rather than theirs.

· 5 min read

LegitScript certification explained

Who actually requires LegitScript certification, and why they do

Nobody is legally required to hold LegitScript certification, but the card networks, acquiring banks, advertising platforms and marketplaces that a telehealth business depends on have each independently adopted it as an entry condition, which is why the requirement reaches you through four different counterparties at once.

· 5 min read

Eligibility and certification categories

Compounded products and certification eligibility

Selling compounded medicines does not make a telehealth business ineligible for LegitScript certification, but it does move the application into the category where the largest number of FDA warning letters in this sector have been issued, nearly all of them over how the product was described.

· 5 min read

Expedited filing versus self-filing

What a denied application actually costs, and it is mostly not the fee

The LegitScript application fee is nonrefundable regardless of outcome, so a denial spends it and a refiling spends it again, but the larger cost is that card processing and paid search stay blocked through the whole of the second review as well as the first.

· 5 min read

Direct-to-consumer telehealth brands

Marketing compounded GLP-1 products without writing your own warning letter

Every FDA warning letter issued to a telehealth or compounding company over compounded GLP-1 marketing turns on how the product was described, which makes the sentence under the product photograph the single most reviewed asset a weight management brand owns.

· 6 min read

LegitScript certification explained

What the LegitScript seal and the public listing actually signal

The certification seal is a licensed asset that stays LegitScript property, and the public listing entry it points at is what acquirers and ad platforms actually check, which makes the listing the load-bearing half and the badge on your footer the decorative one.

· 5 min read

Eligibility and certification categories

503A or 503B: what a reviewer asks about your compounder

A 503A pharmacy compounds for an identified individual patient pursuant to a prescription while a 503B outsourcing facility registers with the FDA and may produce in bulk under manufacturing standards, and telehealth brands routinely describe their partner as the wrong one.

· 5 min read

Expedited filing versus self-filing

The rework loop that stalls self-filed applications

Applicant responsiveness and the sufficiency of the answers given are two of the four factors LegitScript names as deciding review length, which is why a self-filed application usually stalls in a loop of its own making rather than on anything the certifier did.

· 6 min read

Direct-to-consumer telehealth brands

Why direct-to-consumer telehealth brands fail on the landing page

A direct-to-consumer telehealth brand is reviewed on the pages its patients actually see, which is why brands with sound clinical models and credentialed prescribers still fail LegitScript review on a funnel domain nobody in the business considered part of the application.

· 6 min read